Cargando…

Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study

BACKGROUND AND AIM: The COVID‐19 is a stigmatizing infectious disease even after healing. Until now, no COVID‐19 stigma scale validated in Tunisian Arabic language among the general population is available. Developing such tools is necessary to detect COVID‐19 stigma and reduce it effectively. Indee...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlouki, Imen, Zammit, Nawel, Ghammem, Rim, Ben Fredj, Sihem, Bannour, Rania, El Echi, Ansar, Ladhari, Hafsia, Haddedi, Adel, Ghodhbani, Mohamed Mizouni, Maatoug, Jihene, Ghannem, Hassen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855630/
https://www.ncbi.nlm.nih.gov/pubmed/35224221
http://dx.doi.org/10.1002/hsr2.520
_version_ 1784653691829092352
author Mlouki, Imen
Zammit, Nawel
Ghammem, Rim
Ben Fredj, Sihem
Bannour, Rania
El Echi, Ansar
Ladhari, Hafsia
Haddedi, Adel
Ghodhbani, Mohamed Mizouni
Maatoug, Jihene
Ghannem, Hassen
author_facet Mlouki, Imen
Zammit, Nawel
Ghammem, Rim
Ben Fredj, Sihem
Bannour, Rania
El Echi, Ansar
Ladhari, Hafsia
Haddedi, Adel
Ghodhbani, Mohamed Mizouni
Maatoug, Jihene
Ghannem, Hassen
author_sort Mlouki, Imen
collection PubMed
description BACKGROUND AND AIM: The COVID‐19 is a stigmatizing infectious disease even after healing. Until now, no COVID‐19 stigma scale validated in Tunisian Arabic language among the general population is available. Developing such tools is necessary to detect COVID‐19 stigma and reduce it effectively. Indeed, stigmatization of COVID‐19 patients could increase the spread of this disease and its related mental health issues. We aimed at testing the validity of a translated and modified version of the 12‐item HIV stigma scale among Tunisian COVID‐19 patients. METHODS: A cross‐sectional study was conducted between November and December 2020 among a representative sample of COVID‐19 patients in the governorate of Sousse, Tunisia, after quarantine. The 12‐item HIV stigma scale was translated in Tunisian Arabic and then modified to be adapted to the Tunisian context. The preliminary modified version was administrated to the participants by pretrained medical doctors during phone calls. It consisted on 20 items covering the four stigma dimensions (personalized stigma, disclosure concerns, concerns with public attitudes, and negative self‐image). The psychometric evaluation of this version included internal consistency as well as principal component analysis (PCA). RESULTS: The responses of 346 COVID‐19 patients were obtained. Their median age was 40 years (interquartile range: 30‐54.5). Females represented 60.4% of them. The PCA resulted in a three factor solution with 14 items. This 14‐item scale demonstrated good internal consistency with a global Cronbach's α of 0.91 and values of 0.94, 0.93, and 0.98 for social stigma, negative self‐image, and disclosure concerns, respectively. CONCLUSION: This study provides a reliable and valid instrument for stigma measuring among Tunisian COVID‐19 patients. The use of this scale would contribute in reducing the spread of this new infectious disease and its related mental health issues.
format Online
Article
Text
id pubmed-8855630
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88556302022-02-25 Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study Mlouki, Imen Zammit, Nawel Ghammem, Rim Ben Fredj, Sihem Bannour, Rania El Echi, Ansar Ladhari, Hafsia Haddedi, Adel Ghodhbani, Mohamed Mizouni Maatoug, Jihene Ghannem, Hassen Health Sci Rep Original Research BACKGROUND AND AIM: The COVID‐19 is a stigmatizing infectious disease even after healing. Until now, no COVID‐19 stigma scale validated in Tunisian Arabic language among the general population is available. Developing such tools is necessary to detect COVID‐19 stigma and reduce it effectively. Indeed, stigmatization of COVID‐19 patients could increase the spread of this disease and its related mental health issues. We aimed at testing the validity of a translated and modified version of the 12‐item HIV stigma scale among Tunisian COVID‐19 patients. METHODS: A cross‐sectional study was conducted between November and December 2020 among a representative sample of COVID‐19 patients in the governorate of Sousse, Tunisia, after quarantine. The 12‐item HIV stigma scale was translated in Tunisian Arabic and then modified to be adapted to the Tunisian context. The preliminary modified version was administrated to the participants by pretrained medical doctors during phone calls. It consisted on 20 items covering the four stigma dimensions (personalized stigma, disclosure concerns, concerns with public attitudes, and negative self‐image). The psychometric evaluation of this version included internal consistency as well as principal component analysis (PCA). RESULTS: The responses of 346 COVID‐19 patients were obtained. Their median age was 40 years (interquartile range: 30‐54.5). Females represented 60.4% of them. The PCA resulted in a three factor solution with 14 items. This 14‐item scale demonstrated good internal consistency with a global Cronbach's α of 0.91 and values of 0.94, 0.93, and 0.98 for social stigma, negative self‐image, and disclosure concerns, respectively. CONCLUSION: This study provides a reliable and valid instrument for stigma measuring among Tunisian COVID‐19 patients. The use of this scale would contribute in reducing the spread of this new infectious disease and its related mental health issues. John Wiley and Sons Inc. 2022-02-18 /pmc/articles/PMC8855630/ /pubmed/35224221 http://dx.doi.org/10.1002/hsr2.520 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Mlouki, Imen
Zammit, Nawel
Ghammem, Rim
Ben Fredj, Sihem
Bannour, Rania
El Echi, Ansar
Ladhari, Hafsia
Haddedi, Adel
Ghodhbani, Mohamed Mizouni
Maatoug, Jihene
Ghannem, Hassen
Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
title Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
title_full Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
title_fullStr Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
title_full_unstemmed Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
title_short Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
title_sort validity and reliability of a modified short version of a stigma scale for use among tunisian covid‐19 patients after quarantine: a cross‐sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855630/
https://www.ncbi.nlm.nih.gov/pubmed/35224221
http://dx.doi.org/10.1002/hsr2.520
work_keys_str_mv AT mloukiimen validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT zammitnawel validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT ghammemrim validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT benfredjsihem validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT bannourrania validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT elechiansar validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT ladharihafsia validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT haddediadel validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT ghodhbanimohamedmizouni validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT maatougjihene validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy
AT ghannemhassen validityandreliabilityofamodifiedshortversionofastigmascaleforuseamongtunisiancovid19patientsafterquarantineacrosssectionalstudy